British Government Launches Pilot Program For Weight-Loss Shots To Tackle Shortage Of Novo Nordisk's Wegovy
Portfolio Pulse from Vandana Singh
The British government is launching a £40 million pilot program to explore the use of weight-loss shots like Novo Nordisk's Wegovy for obese patients. The program comes in response to a recommendation by the National Institute for Health and Care Excellence. The market launch of Wegovy remains uncertain, and Eli Lilly has expressed interest in contributing once its Mounjaro drug receives approval.
June 07, 2023 | 6:30 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Eli Lilly has expressed interest in contributing to the British government's weight-loss pilot program once its Mounjaro drug receives approval.
Eli Lilly's interest in contributing to the pilot program is a positive sign, but the impact on the stock price is limited in the short term as the Mounjaro drug still needs approval.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 60
NEUTRAL IMPACT
Novo Nordisk's Wegovy is part of a £40 million pilot program launched by the British government to explore weight-loss shots for obese patients. The market launch remains uncertain.
The pilot program is a positive development for Novo Nordisk's Wegovy, as it shows interest in the drug. However, the market launch remains uncertain, which could limit the short-term impact on the stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80